SLLK, Control Peptide for TSP1 Inhibitor (TFA)
SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.
Product Specifications
UNSPSC
12352209
Target
TGF-β Receptor
Type
Peptides
Related Pathways
TGF-beta/Smad
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SLLK,_Control_Peptide_for_TSP1_Inhibitor_TFA_.html
Purity
99.83
Solubility
H2O : ≥ 100 mg/mL
Smiles
O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N)=O)=O)=O)[C@H](CO)N.OC(C(F)(F)F)=O
Molecular Formula
C23H43F3N6O7
Molecular Weight
572.62
References & Citations
[1]Lu A, et al. Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am J Pathol. 2011 Jun;178 (6) :2573-86.|[2]Krishna SM, et al. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse. Arterioscler Thromb Vasc Biol. 2015 Feb;35 (2) :389-98.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
E9008-62A-PE 200 µL
EXOSC8, CT (Exosome Complex Exonuclease RRP43, Ribosomal RNA-processing Protein 43, Exosome Component 8, p9, Opa-interacting Protein 2, OIP2, RRP43) (PE) discontinued
Sign In for Pricing
View Details GTR15381397 1 Vial
Lentiviral human ZC3H11A sgRNA gene knockout kit - Lentiviral human ZC3H11A sgRNA gene knockout kit (100)
Sign In for Pricing
View Details 
N0018-01H-FITC 200 µL
NR4A1 (S351) (Nuclear Receptor Subfamily 4 Group A Member 1, Orphan Nuclear Receptor TR3, Orphan Nuclear Receptor HMR, Early Response Protein NAK1, Testicular Receptor 3, ST-59, Nur77, GFRP1, HMR, NAK1) (FITC) discontinued
Sign In for Pricing
View Details 